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Abstract
Background: Ribosome biogenesis is required for protein synthesis and cell proliferation. Ribosome subunits are assembled
in the nucleolus following transcription of a 47S ribosome RNA precursor by RNA polymerase I and rRNA processing to
produce mature 18S, 28S and 5.8S rRNAs. The 18S rRNA is incorporated into the ribosomal small subunit, whereas the 28S
and 5.8S rRNAs are incorporated into the ribosomal large subunit. Pol I transcription and rRNA processing are coordinated
processes and this coordination has been demonstrated to be mediated by a subset of U3 proteins known as t-UTPs. Up to
date, five t-UTPs have been identified in humans but the mechanism(s) that function in the t-UTP(s) activation of Pol I
remain unknown. In this study we have identified 1A6/DRIM, which was identified as UTP20 in our previous study, as a
t-UTP. In the present study, we investigated the function and mechanism of 1A6/DRIM in Pol I transcription.
Methodology/Principal Findings: Knockdown of 1A6/DRIM by siRNA resulted in a decreased 47S pre-rRNA level as
determined by Northern blotting. Ectopic expression of 1A6/DRIM activated and knockdown of 1A6/DRIM inhibited the
human rDNA promoter as evaluated with luciferase reporter. Chromatin immunoprecipitation (ChIP) experiments showed
that 1A6/DRIM bound UBF and the rDNA promoter. Re-ChIP assay showed that 1A6/DRIM interacts with UBF at the rDNA
promoter. Immunoprecipitation confirmed the interaction between 1A6/DRIM and the nucleolar acetyl-transferase hALP. It
is of note that knockdown of 1A6/DRIM dramatically inhibited UBF acetylation. A finding of significance was that 1A6/DRIM
depletion, as a kind of nucleolar stress, caused an increase in p53 level and inhibited cell proliferation by arresting cells at
G1.
Conclusions: We identify 1A6/DRIM as a novel t-UTP. Our results suggest that 1A6/DRIM activates Pol I transcription most
likely by associating with both hALP and UBF and thereby affecting the acetylation of UBF.
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Introduction
In eukaryotes, the nucleolus is a compartment for ribosome
biosynthesis which includes transcription of ribosomal RNA
precursor (pre-rRNA), processing of pre-rRNA, and assembly of
ribosomal subunits. The ribosomal gene (rDNA) is first transcribed
byRNApolymeraseI (Pol I)toproduce a47Spre-rRNAcontaining
the sequences for 59- external transcribed spacer (59-ETS), 18S
rRNA, internal transcribed spacer-1 (ITS1), 5.8S rRNA, internal
transcribed spacer-2 (ITS2), 28S rRNA and 39- external transcribed
spacer (39-ETS). After chemical modification at numerous sites, the
47S pre-rRNA is processed to produce 18S rRNA, 5.8S rRNA, and
28S rRNA. The 18S rRNA is incorporated into the ribosomal small
subunit, whereas the 28S and 5.8S rRNAs are incorporated into the
ribosomal large subunit.
In humans, transcription by Pol I requires the upstream binding
factor (UBF), and the TBP-containing promoter selectivity factor
SL-1 in addition to RNA Pol I [1], [2]. UBF is a high mobility
group (HMG) box sequence-specific DNA-binding protein, which
binds to the rDNA promoter and recruits SL1 [3], [4], [5]. SL1 is
a species-specific complex which includes TBP, TAFII48, TAFII
63 and TAFII110 and is essential for reconstitution of Pol I
transcription [6], [7], [8]. As a key component in Pol I
transcription, UBF activity is tightly regulated by association with
transcriptional factors and itself undergoing posttranslational
modifications. Under different cell growth conditions, the activity
of UBF is controlled mainly by phosphorylation and acetylation.
UBF is phosphorylated at multiple sites in growing cells [9], [10],
but is hypophosphorylated and transcriptionally inactive in
quiescent cells [11], [12]. Acetylation of UBF also differs during
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control of rDNA transcription. UBF is acetylated in S and G2
phase and is deacetylated in mitosis and early G1 [13]. For
acetylation of UBF, CBP and Rb-HDAC are key regulators which
function in a ‘‘flip-flop’’ manner [14]. It has been found that
acetylation and deacetylation regulate UBF activity without
affecting its DNA binding properties. Instead, UBF acetylation
activates Pol I transcription by enhancing the association between
UBF and Pol I components [15].
Pol I transcription and pre-rRNA processing are believed to be
coordinated in plants, yeast and mammalian cells [16], [17]. This
coordination takes place in a ‘‘terminal knob’’ that is visible under
electron microscopy which is a large 90S pre-ribosome complex
known as ribosomal small subunit (SSU) processome [18], [19],
[20], [21]. This SSU processome contains 12S U3 snoRNP,
MPP10 complex, t-UTPs, bUTP, BMS/RCL1 complex, RNA
helicases and RNA-binding proteins [22]. The coordination
between Pol I transcription and rRNA processing is mediated by
t-UTPs which are required for both 18S rRNA processing and Pol
I transcription, and in addition, are associated with rDNA [23]. A
nucleolar protein may be identified as a classical UTP if it is
associated with U3 snoRNA and its depletion results in inhibition
of 18S rRNA processing but does not affect Pol I transcription. Up
to now, only seven UTPs have been identified as t-UTPs in yeast
including UTP4, UTP5, UTP8, UTP9, UTP10, UTP15 and
UTP17 [23]. Human orthologs of yeast UTP4, UTP5, UTP10,
UTP15 and UTP17 have been identified as t-UTPs, but BLAST
searches have failed to identify orthologs of yeast UTP8 and UTP9
in humans [24]. However, the mechanisms by which these t-UTPs
function in Pol I transcription remain undetermined.
Our previous study identified 1A6/DRIM as the human
UTP20 which functions mainly in the processing of 18S rRNA
[25]. Proteomics studies have found that yeast UTP20 (YBL004w)
resides in the 90S preribosome in the nucleolus [26], [27].
However, whether 1A6/DRIM is a classical UTP or a t-UTP
remains unknown. In the present study, we investigated the
function of 1A6/DRIM in Pol I transcription and found that 1A6/
DRIM functions as a t-UTP. Further study demonstrated that
1A6/DRIM affected UBF acetylation and raises the possibility
that there is a novel mechanism by which t-UTPs activate Pol I
transcription via altering modification of UBF or other Pol I
transcription preinitiation complex factors.
Results
Knockdown of 1A6/DRIM results in a decrease of 47S pre-
rRNA
The47Spre-rRNAistranscribed byPol I and the extreme 59 end
of the external transcribed sequence of the 47S pre-rRNA is rapidly
processed in the cell, so it was used for Northern blotting to
determine the rate of Pol I transcription initiation [28]. To
determine whether 1A6/DRIM functions in Pol I transcription,
47S rRNA level was evaluated with Northern blotting when 1A6/
DRIM was silenced by siRNA. The oligonucleotide used as a probe
for Northern blotting for detecting 47S rRNA was described
previously [29] and is illustrated in Figure 1A. Figure 1B shows that
the47S rRNA levelwasdecreased in1A6/DRIMdeficient cells(left
panel). This experiment was repeated three times and the difference
in the densitometry scanning of the 47S rRNA bands is shown in
Figure 1B (right panel). This result suggested that knockdown of
1A6/DRIM considerably inhibited 47S rRNA transcription.
Inhibition of 47S rRNA transcription by knockdown of 1A6/
DRIM was confirmed by real time PCR. Reverse transcription was
carried out with total RNA extracted from U2OS cells after 1A6/
DRIM was silenced. Real time PCR was performed with primers
amplifying the extreme 59 end of the external transcribed sequence
of the pre-rRNA. As shown in Figure 1C, the level of 47S rRNA
significantly decreased in 1A6/DRIM depleted cells as compared
with the control siRNA treated cells.
1A6/DRIM activated the rDNA promoter luciferase
reporter
The human rRNA promoter luciferase reporter plasmid pHrD-
IRES-Luc has been demonstrated to reflect Pol I transcription
Figure 1. Knockdown of 1A6/DRIM results in a decrease in 47S
rRNA. A. Cartoon illustrating the location of the probe on the 47S rRNA
used for Northern blotting to detect 47S rRNA transcript. B. A 1A6/DRIM
specific siRNA (si2-8) was transfected into U2OS cells. RNA was extracted
72 hours posttransfection, resolved on a 1% glyoxal-agarose gel and
transferred onto a positively charged nylon membrane. Blots were probed
with a Biotin-labeled DNA oligonucleotide (as shown in A) to detect 47S
rRNA (left upper panel). Ethidium Bromide (EB) staining of the 28S rRNA on
the agarose gel was used as a loading control. Cell lysates were prepared
72 hours after siRNA transfection and proteins from the lysates were
separated on SDS-PAGE and transferred onto a PVDF membrane. Blots
were probed with anti-1A6/DRIM antibody. Topoisomerase I (Topo I) was
used as a loading control (left lower). The experiment was repeated three
times and the difference in the densitometry scanning of the 47S rRNA
bands is displayed in the right panel. C. A 1A6/DRIM specific siRNA (si2-8)
was transfected into U2OS cells. RNA was extracted 72 hours posttransfec-
tion and reverse transcription was carried out. Real time PCR was
performed with primers amplifying the 59-extreme end fragment of the
47S rRNA. The experiment was repeated three times in duplicate and the
statistical significance of the difference is shown. Statistical analyses were
performed with two-tailed unpaired t test.
doi:10.1371/journal.pone.0014244.g001
1A6/DRIM Activates Pol I
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transcription, pHrD-IRES-Luc was constructed as described
previously [30] and was transfected into U2OS cells 48 hours
after transfection with 1A6/DRIM-specific siRNA. Luciferase
activity was determined 24 hours after transfection with pHrD-
IRES-Luc. Figure 2A shows that knockdown of 1A6/DRIM
inhibited the activity of pHrD-IRES-Luc. In addition, plasmid
coding Flag-1A6/DRIM was cotransfected with pHrD-IRES-Luc
into U2OS cells and luciferase activity was measured 24 hours
posttransfection. As shown in Figure 2B, 1A6/DRIM activated the
pHrD-IRES-Luc reporter in a dose-dependent manner. Taken
together, these results demonstrated that 1A6/DRIM activates Pol
I transcription.
1A6/DRIM bound the rDNA promoter and interacted
with UBF at the promoter
To determine whether 1A6/DRIM binds rDNA in cells,
chromatin immunoprecipitation experiments (ChIP) were per-
formed with anti-1A6/DRIM antibody. A DNA fragment from
the rDNA promoter was amplified by PCR with DNA extracted
from 1A6/DRIM specific immunoprecipitates. Figure 3A shows
1A6/DRIM bound rDNA promoter. In this experiment, UBF
which is known to be an rDNA binding transcription factor was
used as a positive control.
To determine whether 1A6/DRIM is associated with UBF,
immunoprecipitation was performed with anti-1A6/DRIM anti-
body and UBF was evaluated by Western blotting on 1A6/DRIM-
specific immunoprecipitates. Figure 3B shows that UBF was
present in the 1A6/DRIM-specific immunocomplex, demonstrat-
ing that 1A6/DRIM was associated with UBF. We also examined
TAFI 110 from 1A6/DRIM-specific immunoprecipitates. As
shown in Figure 3B, TAFI 110 was not found in the 1A6/
DRIM-specific immunocomplex, indicating that 1A6/DRIM
specifically interacts with UBF. UBF has two isoforms including
the 97kD UBF-1 and the 94kD UBF-2 [31]. UBF-1 is known as
the constitutively active form of UBF, whereas UBF-2 is
responsible for tuning the response of ribosomal RNA genes to
growth factor stimulation [32]. It is notable that UBF-1 was
enriched in the 1A6/DRIM immunoprecipitates, suggesting 1A6/
DRIM may affect UBF activity by specifically interacting with
UBF-1. To demonstrate that 1A6/DRIM and UBF form a
complex on rDNA, a re-ChIP experiment was performed. A ChIP
assay was first performed with 1A6/DRIM-specific antibody, and
the precipitates were subjected to re-ChIP assay with UBF
antibody. As shown in Figure 3C, the rDNA promoter sequence
was amplified from the re-ChIP precipitate, demonstrating that
1A6/DRIM bound UBF at the rDNA promoter.
1A6/DRIM is associated with hALP and knockdown of
1A6/DRIM inhibits UBF acetylation
To determine the mechanisms by which 1A6/DRIM functions
in Pol I transcription, we isolated 1A6/DRIM-interacting proteins
using the yeast two-hybrid assay. A nucleolar acetyl-transferase
hALP was found to interact with 1A6/DRIM, and we found that
hALP activated Pol I transcription by acetylating UBF (manuscript
submitted). We then performed immunoprecipitation with 1A6/
DRIM specific antibody 6D9 to confirm the interaction between
1A6/DRIM and hALP. As shown in Figure 4A, hALP indeed
interacted with 1A6/DRIM. In addition, cellular localization of
1A6/DRIM and hALP was analyzed with indirect immunofluo-
rescence. Figure 4B shows that 1A6/DRIM colocalized with
hALP in the nucleolus, further confirming the interaction between
1A6/DRIM and hALP. We next sought to determine whether
Figure 2. 1A6/DRIM activates rDNA promoter luciferase
reporter. A. A 1A6/DRIM specific siRNA (si2-8) was transfected into
U2OS cells. pHrD-IRES-Luc plasmid was transfected into the cells
48 hours after transfection of siRNA. Luciferase activity was measured
24 hours after transfection of pHrD-IRES-Luc. Results which are
summarized from three independent repetitions of the experiments
are shown (upper panel). Proteins from the above transfection were
subjected to Western blotting for detection of 1A6/DRIM (lower panel).
Topoisomerase I (Topo I) was used as a loading control. B. pHrD-IRES-
Luc plasmid was cotransfected with increasing amounts of pCI-neo-
Flag-1A6/DRIM plasmid. Luciferase activity was measured 24 hours after
transfection. Results are summarized from three independent experi-
ments in duplicate (upper panel). Cell lysates were prepared 24 hours
after transfection and proteins from cell lystaes were separated by SDS-
PAGE and transferred onto a PVDF membrane. The upper part of the
blot was probed with anti-Flag antibody M2 and the lower part was
probed with anti-topoisomerase I (Topo I) as a loading control.
doi:10.1371/journal.pone.0014244.g002
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performed with anti-acetyl-lysine antibody on cell lysates extracted
from 1A6/DRIM depleted U2OS cells or a control siRNA treated
cells. Proteins from the immunoprecipitates were subjected to
Western blotting for detection of hALP. Figure 4C shows that
UBF acetylation was dramatically inhibited in 1A6/DRIM
depleted cells and the total protein level of UBF was not changed
by 1A6/DRIM knockdown (Figure 4C, lower panel). We asked if
knockdown of 1A6/DRIM specifically affects acetylation of UBF.
To address this issue, acetylation of RB was evaluated after 1A6/
DRIM was depleted. Immunoprecipitation was performed with
anti-acetyl-lysine antibody on cell lysates extracted from 1A6/
DRIM depleted U2OS cells or a control siRNA treated cells.
Proteins from the immunoprecipitates were subjected to Western
blotting for detection of RB. As shown in Figure 4C (upper panel),
Figure 3. 1A6/DRIM bound rDNA promoter and interacted with
UBF at the rDNA promoter. A. Chromatin immunoprecipitation
(ChIP) was performed with antibodies directed against either 1A6/DRIM
or UBF. Mouse IgG (mIgG) was used as an antibody control. A DNA
fragment of the rDNA promoter sequence was amplified by PCR. DNA
fragments from either the U6 or GAPDH promoter were amplified as
controls. The PCR products were resolved on a 2% agarose gel and
stained with EB. B. Whole cell lysate was extracted from U2OS cells.
Immunoprecipitation was carried out with anti-1A6/DRIM antibody.
Proteins from 1A6/DRIM specific immunoprecipitates were separated
on SDS-PAGE and blotted onto PVDF membranes. The upper part of the
blot was probed with anti-1A6/DRIM antibody and the lower part of the
same blot was hybridized with anti-UBF antibody or anti-TAFI110
antibody. C. Re-ChIP experiment was performed to confirm that 1A6/
DRIM bound UBF at the rDNA promoter. ChIP was performed using an
anti-1A6/DRIM antibody. Re-ChIP was carried out using either mouse
IgG (mIgG) or an anti-UBF antibody. A DNA fragment of the rDNA
promoter sequence was amplified by PCR. DNA fragments from either
the U6 or GAPDH promoter were amplified as controls. The PCR
products were resolved on a 2% agarose gel and stained with EB.
doi:10.1371/journal.pone.0014244.g003
Figure 4. 1A6/DRIM was associated with hALP and knockdown
of 1A6/DRIM inhibited UBF acetylation. A. Immunoprecipitation
was performed with the 1A6/DRIM-specific monoclonal antibody 6D9.
Proteins from the immunoprecipitates were separated by SDA-PAGE
and transferred onto a PVDF membrane. The upper part of the blot was
hybridized with 1A6/DRIM antibody and the lower part was probed
with anti-hALP antibody. B. Indirect immunofluorescence staining was
performed with a monoclonal antibody directed against 1A6/DRIM and
a hALP-specific polyclonal antibody. 1A6/DRIM specific immunocom-
plexes were detected with TRITC-conjugated anti-mouse IgG and hALP
specific immunocomplexes were detected with FITC-conjugated anti-
rabbit IgG. Images were photographed under confocal microscopy after
the nucleus was stained with DAPI. C. A 1A6/DRIM specific siRNA (si2-8)
was transfected into U2OS cells. Cell lysate was prepared 72 hours
posttransfection. Immunoprecipitation was performed with anti-acetyl-
lysine on the cell lysates. Proteins from the immunoprecipitates were
separated on SDS-PAGE and transferred onto a PVDF membrane. Blots
were probed with anti-UBF antibody or anti-RB antibody (upper panel).
Proteins from the whole cell lysates (WCE) were directly subjected to
Western blotting to detect protein levels of indicated proteins (lower
panel). Topoisomerase I (Topo I) was used as a loading control.
doi:10.1371/journal.pone.0014244.g004
1A6/DRIM Activates Pol I
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demonstrating that 1A6/DRIM specifically affects acetylation of
UBF. It was also shown that depletion of 1A6/DRIM had no
effects on protein levels of hALP or on levels of Pol I subunit
RPA194 and the Pol I associated factor 53 (PAF53). In addition,
protein levels of TBP and SL1 complex components including
TAFI110, TAFI63 and TAFI48 were not affected by knockdown of
1A6/DRIM (Figure 4C, lower panel).
Knockdown of 1A6/DRIM causes p53 activation and
inhibits cell proliferation by arresting cells at G1
It has been found that disruption of nucleolar function activates
p53 [33]. The level of p53 protein increased when 1A6/DRIM
was silenced in U2OS cells, as shown in Figure 5A, and in
addition, p21 was activated in 1A6/DRIM depleted cells. To
study the biological significance of p53 activation resulting from
1A6/DRIM depletion, the cell cycle was analyzed after 1A6/
DRIM silencing in U2OS cells. A representative result is shown in
Figure 5B that knockdown of 1A6/DRIM caused an increased cell
numbers in G1 and decreased cell numbers in S and G2. This
experiment was repeated three times in duplicate and the data is
summarized in Figure 5C. The results showed that there were
63.3% of the cells in G1, 32.1% in S and 4.6% in G2 in 1A6/
DRIM depleted cells, while there were 51.6% of the cells in G1,
38.4% in S and 10.0% in G2 in a control siRNA treated cells
suggesting knockdown of 1A6/DRIM caused arrest of cells at G1
(p,0.05). To confirm this observation, the same experiment was
carried out in MCF-7 cells and identical results were obtained
(data not shown). In addition, the BrdU incorporation assay was
performed to evaluate cell numbers in S phase when 1A6/DRIM
was silenced by siRNA. As shown in Figure 5D the result showed
that knockdown of 1A6/DRIM resulted in significantly fewer cells
in S phase confirming that knockdown of 1A6/DRIM caused cell
arrest at G1. Accordingly, cell proliferation was examined with
colony formation. Figure 5E shows that both of the size and the
number of colonies decreased when 1A6/DRIM was silenced. To
quantify the effect of 1A6/DRIM depletion on cell proliferation, a
cell growth curve was plotted using the Cell Count Kit-8 assay. As
shown in Figure 5F, growth of 1A6/DRIM depleted cells was
significantly inhibited compared to control siRNA treated cells.
Thus, we demonstrated that knockdown of 1A6/DRIM inhibited
cell proliferation by arresting cells at G1.
Discussion
Pol I transcription and rRNA processing are coordinated and
stringently controlled in normal cells. This coordination is
mediated by the interaction of UBF with pre-rRNA processing
factors [17]. The SSU processome has been found to play a role in
the coordination of Pol I transcription and pre-rRNA processing.
The SSU processome is assembled on nascent pre-rRNA as a large
complex with a multimodular structure [34]. While Pol I
transcription is undergoing elongation, the SSU processome
participates simultaneously in pre-rRNA processing. Pre-rRNA
is sequentially cleaved at A0, A1 and A2. Upon cleavage at the A2
site, the pre-40S particle containing major components of the SSU
processome and 18S rRNA departs from the remaining pre-rRNA
on which another subset of ribosomal proteins are recruited to
form the pre-60S particle [34]. It is known that t-UTPs are
required for Pol I transcription and early stages of pre-rRNA
processing. Up to now, only seven t-UTPs have been identified in
yeast and five t-UTPs have been identified in mammalian cells.
However, the mechanisms by which t-UTPs function in Pol I
transcription remain unknown.
Our previous study identified 1A6/DRIM as the human
UTP20 that functions mainly in 18S rRNA processing [25]. The
extreme 59 end of the external transcribed sequence of the pre-
rRNA is rapidly processed in the cell, so it has been used in
Northern blotting to determine the rate of Pol I transcription
initiation [28]. In the present study, we evaluated the level of 47S
rRNA by using the extreme 59 end of the external transcribed
sequence of the pre-rRNA as a probe, and the results showed that
silencing of 1A6/DRIM results in a decreased level of 47S pre-
rRNA, indicating that knockdown of 1A6/DRIM inhibited Pol I
transcription. Since the rRNA promoter is transcribed by Pol I,
the human rRNA promoter luciferase reporter plasmid pHrD-
IRES-Luc has been demonstrated to reflect Pol I transcription
activity [30]. We found that 1A6/DRIM expression activated
rDNA promoter luciferase reporter activity and knockdown of
1A6/DRIM inhibited this activity, further demonstrating that
1A6/DRIM activates Pol I transcription. In addition, 1A6/DRIM
is associated with the rDNA promoter. We therefore can identify
1A6/DRIM as a novel t-UTP. Interestingly, we showed that 1A6/
DRIM specifically interacts with UBF-1, the constitutively active
form of UBF, suggesting the interaction between 1A6/DRIM and
UBF may play an important role in rDNA transcription activation.
t-UTPs functions in a complex to activate Pol I transcription,
and Pol I transcription is regulated mainly by phosphorylation and
acetylation of UBF. We therefore speculated that 1A6/DRIM
might also interact with kinases or acetyl-transferases in addition to
binding with UBF. In our previous study we found several 1A6/
DRIM-interacting proteins by using the yeast two-hybrid assay,
among which was the nucleolar acetyl-transferase, hALP. hALP is
a nucleolar protein with multiple functions in cell division related
to its capacity for acetylating histone and tubulin [35], [36]. This
prompted study of the function of hALP in Pol I transcription and
we found hALP activates Pol I transcription by acetylating UBF
(manuscript submitted). In the present study, the interaction
between 1A6/DRIM and hALP was verified by immunoprecip-
itation and immunofluorescence staining. Importantly, knockdown
of 1A6/DRIM dramatically inhibited UBF acetylation, suggesting
that 1A6/DRIM may affect UBF acetylation by forming and
maintaining an acetyl-transferase-containing complex with UBF.
Thus, we provide a mechanism by which t-UTPs activates Pol I
transcription. We propose that other t-UTPs may function in Pol I
transcription via formation of complexes with kinases, phospho-
tases or other acetyl-transferases to regulate phosphorylation or
acetylation and therefore regulate the activity of UBF.
Nucleolar functional disruptions have been shown to generate
nucleolar stress signaling to p53 [33]. As expected, we found that
knockdown of 1A6/DRIM also activated p53. Defects in ribosome
biogenesis cause p53 activation via a L11-dependent pathway
[37]. However, how knockdown of 1A6/DRIM mediates p53
activation requires further investigation. In the present study,
activation of p53 was verified by an elevated level of p21.
Significantly, knockdown of 1A6/DRIM arrested cells at G1.
Consistent with this result, 1A6/DRIM depletion inhibited cell
proliferation. Up to this point, we have demonstrated that 1A6/
DRIM is a novel t-UTP which activates Pol I transcription at least
partly by regulating UBF modification. UBF is deacetylated in
mitosis and early G1 and is acetylated in S and G2 phase [13]. We
propose that 1A6/DRIM may facilitate acetylation of UBF at late
G1 and therefore promotes cell cycle progression from G1 to S
phase. In addition, cell growth is controlled by protein synthesis
which is dependent on ribosome biogenesis. Thus, we suggest that
1A6/DRIM promotes cell proliferation via its function in
activation of rRNA transcription by Pol I and subsequent rRNA
processing.
1A6/DRIM Activates Pol I
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ation, and deregulation of these factors, such as Pes1 which
functions in 28S rRNA processing, often causes tumorigenesis
[38], [39]. Moreover, 1A6/DRIM has been found to be
upregulated in some tumors (our unpublished data) and we are
therefore currently investigating the 1A6/DRIM expression
profile in human tumors to determine whether 1A6/DRIM can
be used as a diagnostic marker or a therapeutic target in human
tumors.
Materials and Methods
Cell culture and 1A6/DRIM RNAi
U2OS and MCF-7 cells were obtained from the American Type
Culture Collection (ATCC) and were grown according to the
instructions provided by the ATCC. Cells were incubated in a
humidified atmosphere with 5% CO2 at 37uC. For silencing 1A6/
DRIM expression, three siRNAs targeting 1A6/DRIM were
chemically synthesized as follows: si1-1: 59- GACAAAGCCC-
GUUUCCCAC-39; si2-8: 59-GCCAUAGCCUGAAAGAUUU-
39; si3-1: 59- GGCAAAGUUGUUCUGUCUU-39; together with
synthesis of an unrelated siRNA (siNC: 59-ACUACCGUU-
GUUAUAGGUG-39) for a control (Shanghai GenePharma Co.,
Ltd). The synthesized siRNA was transfected into cells at a
concentration of 100 nM with Lipofectamine 2000
TM (Invitrogen)
according to the manufacturer’s instructions.
Plasmids
A plasmid coding Flag-1A6/DRIM was generated by inserting
the 1A6/DRIM cDNA fragment obtained by RT-PCR into pCI-
neo-Flag. A human rDNA promoter-luciferase reporter pHrD-
IRES-Luc was constructed as previously described [30].
Preparation of cellular extracts and immunoprecipitation
Immunoprecipitation was performed as described previously
[40]. Briefly, U2OS cell lysates were prepared in NET buffer
(150 mM NaCl, 5 mM EDTA, 50 mM Tris-Cl [pH7.5]) supple-
mented with 1% NP-40 and protein cocktail inhibitor. Cell lysates
were incubated with anti-1A6/DRIM anbibody 6D9 or mouse
IgG crosslinked protein A sepharose beads (Amersham Bioscienc-
es) for 4 h at 4uC. After washing twice with NET+1% NP-40 and
twice with NET buffer, the precipitated proteins were subjected to
Western blotting.
Immunoblotting
Proteins were separated on SDS-PAGE and transferred onto
PVDF membranes (Amersham Biosciences). Blots were probed
Figure 5. Knockdown of 1A6/DRIM activated p53 and inhibited
cell proliferation by arresting cells at G1. A. U2OS cells were
transfected with three 1A6/DRIM siRNAs(si1-1, si2-8 andsi3-1) andwhole
cell extracts were prepared 72 hours posttransfection. Proteins from the
extracts were separated on SDS-PAGE, and transferred onto a PVDF
membrane. Blots were probed with antibodies directed against 1A6/
DRIM,p53 orp21.Beta-actinwasusedasaloadingcontrol.BandC.U2OS
cells were transfected with a 1A6/DRIM siRNA (si2-8). The cell cycle was
analyzed with flow cytometry 72 hours posttransfection. A representa-
tiveresultisshowninBandasummaryofresultsfromthreeindependent
experiments is shown in C. D. U2OS cells were transfected with a 1A6/
DRIM siRNA (si2-8). Cells were pulsed for 16 hours with BrdU, and were
then stained with FITC-conjugated anti-BrdU and 7-AAD. BrdU and
7-AAD staining were analyzed by FACScan (Becton Dickinson). S-phase
population was plotted by comparing FITC (DNA incorporation) vs.
7-AAD (total DNA) staining. Shown is the data summarized from three
independent experiments in duplicate. E.U2OS cells were transfected
with a 1A6/DRIM siRNA (si2-8). Two thousand cells were seeded in 6 mm
plates 72 hours posttransfection. Cells were grown for 10 days and cell
colonies were stained with Coomassie Bright Blue after fixation with
ethanol/acetic acid. F. U2OS cells were transfected with a 1A6/DRIM
siRNA (si2-8). Cells were seeded in 96-well plates 72 hours posttransfec-
tion. Ten microliters of CCK-8 was added to the cells and absorbance at
450 nm was measured at different time periods. The experiment was
repeated three times in duplicate and growth curves were plotted using
absorbance at 450 nm vs. different time points. Statistics analysis was
performed with two-tailed unpaired t-test in C and D.
doi:10.1371/journal.pone.0014244.g005
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secondary antibodies. Immunocomplexes were detected with ECL
Western blot Detection Reagent (GE Healthcare) before exposure
to X-ray film.
ChIP assay
Chromatin immunoprecipitation (ChIP) was performed as
described previously [41]. Briefly, cells were fixed with 1%
formaldehyde. Immunoprecipitation was performed with antibod-
ies coupled to protein A/G-Sepharose. Immunoprecipitated
chromatin-derived DNA was analyzed by PCR with primers
specific for the rDNA promoter as described previously [42]
(forward primer: 59-CGCTGCTCCCGCGTGTGTCC-39; re-
verse primer: 59-CAGCGACAGGTCGCCAGAGG-39). The
primer sequences used to amplify U6 and GAPDH promoters
were as described previously [43]. PCR products were resolved on
agarose gel and visualized with ethidium bromide.
Northern blotting and RT-PCR
For detection of 47S rRNA, RNA was resolved on a 1% glyoxal-
agarose gel (NorthernMaxH-Gly kit, Ambion) and blotted onto
BrightStarH-PLUS positively charged Nylon membranes (Ambion).
DNA oligonucleotide was biotin-labeled with a Biotin 39 End DNA
Labeling Kit (PIERCE) to probe for 47S rRNA and the sequence of
the oligonucleotide which was employed was as described
previously [29]: 59- CCTCTCCAGCGACAGGTCGCCAGAG-
GACAGCGTGTCAGCAATAACCCGGCGGCCAAAATG-39.
Hybridization was performed as described previously [44] and
hybridized 47S rRNA was detected with the BrightStarH BioDe-
tect
TM Nonisotopic Detection Kit (Ambion). Reverse transcription
was performed with total RNAs using SuperScript
TM II Reverse
Transcriptase (Invitrogen) according to the manufacturer’s instruc-
tions. Real-time PCR for amplification of the 47S rRNA was
performed with the following primers: Forward (+180 to +196): 59-
CGGGTCCGGGTCTCTGA-39; Reverse (+307 to +326): 59-
GGAGACGAGAACGCCTGACA-39.
Immunofluorescence
Cells were plated on coverslips in 6-well plates one day before
harvest. Double indirect immunofluorescence was performed with
the monoclonal anti-1A6/DRIM antibody 6D9 and a polyclonal
antibody directed against hALP after cells were fixed. 1A6/DRIM
specific immunocomplexes were detected with TRITC-conjugated
goat anti-mouse IgG and hALP specific immunocomplexes were
detected with FITC-conjugated goat anti-rabbit IgG. Immunoflu-
orescence signals were recorded by confocal laser scanning
microscopy (Leica TCS-ST2).
Flow cytometry analysis
For DNA content analysis, cells were trypsinized and fixed in
75% ice-cold ethanol at 4uC overnight. Following RNase
digestion, cells were stained with propidium iodide (PI). Flow
cytometry analysis was performed evaluating red (PI) emission (at
630 nm). Data from 10
4 cells were collected and analyzed by using
Cellquest software (Becton Dickinson).
BrdU incorporation assay
The cell population in S-phase was determined with a BD
Pharmingen
TM BrdU Flow Kit according to the manufacturer’s
instructions. Briefly, cells were pulsed for 16 hours with bromo-
deoxyuridine (BrdU), and were then stained with fluorescein
isothiocyanate (FITC)-conjugated anti-BrdU and 7-amino-actino-
mycin D (7-AAD). Positive BrdU staining and 7-AAD staining
were analyzed by FACScan (Becton Dickinson). Data from 10
4
cells were analyzed by using Cellquest software (Becton Dick-
inson). Cells in S-phase were quantitated by comparing FITC
(DNA incorporation) vs. 7-AAD (total DNA) staining.
Growth curve
Growth curves were plotted with a Cell Counting Kit-8 (CCK-8,
Dojindo) according to the manufacturer’s instructions. In brief, cells
were seeded in 96-well plates. CCK-8 [2-(2-methoxy-4-nitrophe-
nyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, mono-
sodium salt] was added to the cells and incubated for 4 hours.
Absorbance at 450 nm was measured using a microplate reader.
The experiment was repeated three times in duplicate. Growth
curves were plotted using the mean 6 SD of absorbance at 450 nm
vs. time points.
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